Dana Pizzuti, the Chief Medical (TASE:PMCN) and Development Officer of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), recently executed a series of stock transactions as disclosed in a recent SEC ...
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) shares fell 5.5% during trading on Monday following insider selling activity. The company traded as low as $32.48 and last traded at $32.33.